BSE filing, BSE: 544036. Summary written from the filing by ALFA Finder's alert engine.
Deepak Chemtex Ltd: key numbers
- Share price
- ₹84.95
- Market cap
- ₹92.29 Cr
- Revenue (annual)
- ₹67.64 Cr
- Net profit (annual)
- ₹8.25 Cr
- P/E (TTM)
- 11.2×Sector 34.5×
- Promoter holding
- 73.05%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Deepak Chemtex Ltd
All →Deepak Chemtex Annual General Meeting
Deepak Chemtex's 29th AGM on September 21, 2026 adopted FY25-26 financials and re-appointed its MD and WTD. Routine resolutions including subsidiary RPT approval were passed.
Deepak Chemtex Other Announcement
Deepak Chemtex Ltd has notified shareholders with unregistered email IDs of the weblink to access the AGM notice and Annual Report for the upcoming meeting.
Deepak Chemtex Annual Report
Deepak Chemtex Ltd has filed its Integrated Annual Report for FY 2025-26, incorporating the notice for the 29th Annual General Meeting scheduled for September 21, 2026.
Deepak Chemtex Annual General Meeting
Deepak Chemtex Ltd's 29th Annual General Meeting is scheduled for September 21, 2026, via video conferencing. The agenda includes director appointments and related-party transaction approvals.
Deepak Chemtex Board Meeting Outcome
Deepak Chemtex approved the Directors' Report for the year ended March 31, 2026. The board also scheduled the company's 29th AGM for September 21, 2026.
Deepak Chemtex Management Change
Mrs. Sonam Sharma has resigned as Company Secretary and Compliance Officer of Deepak Chemtex Limited effective August 17, 2026, due to unavoidable circumstances.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.